Financials
- Financial year
- 2024
- Total assets
- €786,162
- Profit
- €792,322
- Solvency
- 22.0%
Total assets▲ 5.2%
Net result
20182024
FLEURUS MEDICAL
Judicial reorganisationSummary
The file of FLEURUS MEDICAL contains 5 judicial reorganisation notices, as published in the Belgian Official Gazette. The KBO register currently lists the legal status of FLEURUS MEDICAL as special situation, with no start date. During the judicial reorganisation Checked does not compute a bankruptcy probability from the figures: of the Belgian companies that opened one in 2023 and 2024, about one in four went bankrupt within twelve months. The 2024 annual accounts show equity of €173,098 and a net result of €792,322. Equity is shrinking by about 2.7% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2025. Its solvency ranks better than 36% of 6,488 sector peers (NACE 47, financial year 2024).
Are you a creditor?
Judicial reorganisation
Source: Belgian Official Gazette
Your claim still exists, but while the moratorium runs you cannot enforce it. What you do now depends on the track of the reorganisation.
The procedure
- Court
- Enterprise Court of Hainaut
- Opened
- 29 June 2026
- Track
- Reorganisation by transfer under court supervision
- Docket number
- 20260023
- Moratorium until
- 27 November 2026
- Delegated judge
- Jean-Pol Scieur
- Official Gazette
- 24-07-2026 (pdf) ↗search the document for 2026/129984
What to do now
- Do not attach assets or start enforcement for debts from before the opening while the moratorium runs.
- A court officer sells the business or part of it; creditors are paid from the proceeds, according to their ranking.
- What you deliver after the opening is not covered by the moratorium: agree clear payment terms.
- The file is in RegSol, where you can read the documents of the procedure.
Deadlines: the moratorium runs until 27 November 2026, unless the court extends or ends it earlier.
View the file in RegSol ↗
Follow
Follow this reorganisation: you are alerted to an extension, the court's approval, the closure or a bankruptcy.
General information, not legal advice. If in doubt, your lawyer or your accountant can help.Creditor guide for this company
Embed in an article
Writing about this reorganisation? Embed the FLEURUS MEDICAL company card in your article: name, enterprise number, its status in the KBO and the latest annual accounts, with a link to this dossier.
Preview
The preview appears here.
- Stays current: the status follows the register, the figures are those of the latest filed accounts. No Checked score or verdict.
- Light on your page: one small script and one data request, also answered from a cache; no cookies, no tracking.
- Where scripts do not run (a newsletter, a feed reader) a plain link remains.
Overview
Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
NACE 47741
2 sites
Size
€786,162total assets 2024
- Staff
- 1.5 FTE
- Equity
- €173,098
- Profit
- €792,322
Financial health
24
Critical
Checked score 2024Reorganisation running: about 1 in 4 bankrupt within the year
Structure
Accounts 81 days overdue1 of 2 deeds read
Signalsraises riskIn judicial reorganisationAnnual accounts not filedneutralLatest accounts filed on timeShow the evidence
Checked score
Score 2024
24
/ 100
Critical
Without a bankruptcy probability: score from the figures alone
An ongoing judicial reorganisation from the Belgian Official Gazette caps the score at 24. Every signal that counts is listed under Signals.
Financial strength · tick = 2023
Average
Solvency
47+47
equity 22.0% of total assets
Liquidity
10+9
short-term debt 78.0% · cash 2.0%
Profitability
100+100
return on assets 100.8%
Bankruptcy probability, 12 months
Judicial reorganisation
About 1 in 4 comparable companies went bankrupt within the year
A judicial reorganisation is open: we then compute no probability from the figures. Measured over every Belgian company in an open or failed reorganisation: 25% to 26% bankrupt within twelve months (2024 and 2025).
No credit on open account during an ongoing judicial reorganisation
Liquidity insufficient (current ratio 0.84, compared with 0.28 in 2023, below 1; short-term debt: 78% and cash: 2% of total assets), and 78% of the assets are financed with debt and provisions.
Signals
Three signals.
raises riskneutral
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 81 days later.
NBB · 10 filingsPosition against the passed deadline
31-12-2025 year end31-07-2026 deadline20-10-2026 today
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-04-2025, 93 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not filed
2024
93 days early
2023
92 days late
2022
77 days late
2021
61 days late
2020
25 days late
2019
88 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 42 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.
Searched, nothing found (1)
- ExtensionEnterprise Court of Hainaut ·…
- ExtensionEnterprise Court of Hainaut ·…
- Transfer under judicial authorityEnterprise Court of Hainaut, Charleroi…
Key points
By topic
Timeline
- Events
- 46
- Since
- 1991
- 20-11-2025Transfer under judicial authority
- 29-04-2025Annual accounts filed
- 31-12-2024Back to profit
Company details
- Sites
- 2
- Legal form
- Private limited company
- Activity
- Retail sale of medical and orthopaedic goods, excluding…NACE 47741
- Founded
- 17-04-1990
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 28
- Annual meeting
- Second Tuesday of March at 18:00
- Purpose
- “L’achat,la vente,l’importation et l’exportation de matériel médical,de produits…” (deed in French)
Go further with this company
What should you check before you do business with this company?Supplier due diligence What were this company's board, registered office and name on a given date?Company as of a date Are there other customers at risk in your own list?Process a list How is the retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses sector doing?Sector figures
Investigating this company? Keep it with today's facts in a case file.